---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-034401"
form_type: "8-K"
ticker: "GYRE"
cik: "0001124105"
company_name: "GYRE THERAPEUTICS, INC."
filed_at: "2026-08-26T13:00:44+00:00"
generated_at: "2026-08-26T13:02:48.849789+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Gyre posts updated corporate presentation; no financial or clinical data disclosed

## Summary
- On Aug 26, 2026, Gyre Therapeutics, Inc. posted an updated corporate presentation to its website (Exhibit 99.1, dated August 2026).
- Presentation titled 'Building A New Protein Degrader Company For Unmet Medical Needs'; no financial or clinical data appear in the provided text.
- The exhibit text is truncated at a disclaimer page; no revenue, EPS, pipeline, or guidance figures are visible.
- No forward-looking statements, financial metrics, or clinical updates are included in the excerpt furnished.

## SEC filing metadata
- accession: 0001140361-26-034401
- form_type: 8-K
- ticker: GYRE
- cik: 0001124105
- company_name: GYRE THERAPEUTICS, INC.
- filed_at: 2026-08-26T13:00:44+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124105/000114036126034401/0001140361-26-034401-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124105/000114036126034401/ef20081104_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-034401
- JSON: https://secwatch.observer/filing/0001140361-26-034401.json
- Plain text: https://secwatch.observer/filing/0001140361-26-034401.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.